Add BrightSurf on Google Email

Sleep-disordered breathing comes at a heavy cost

People with sleep apnoea or obesity-related respiratory difficulties incur twice as high medicine and hospital costs as healthy control subjects, with unemployment rates 30% higher. Violent snoring costs €705 per person, while sleep apnoea costs €3860 and obesity-related respiratory difficulties cost €11,320.

SourceUniversity of Copenhagen·JournalThorax·DateJan 12, 2011

Pitt researchers discover big role for microRNA in lethal lung fibrosis

Researchers at the University of Pittsburgh School of Medicine have identified a molecular mechanism for idiopathic pulmonary fibrosis (IPF), a chronic and usually lethal disease. The study found that microRNA changes contribute to IPF, with let-7d being significantly reduced in affected tissues.

SourceUniversity of Pittsburgh Schools of the Health Sciences·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateApr 29, 2010

Research validates surgery alone offers reasonable overall survival for stage I SCLC

Research published in Journal of Thoracic Oncology investigates the effectiveness of surgery as a standalone treatment for stage I small cell lung cancer. The study found three- and five-year survival rates of 58.1% and 50.3%, respectively, for patients who underwent lobectomies without radiotherapy.

SourceInternational Association for the Study of Lung Cancer·JournalJournal of Thoracic Oncology·DateFeb 16, 2010

Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients

The Pitt team has made significant progress in understanding the molecular mechanisms of disease exacerbation in IPF patients. By analyzing gene activity patterns and protein levels in lung tissue and blood samples, researchers have identified potential biomarkers for predicting patient outcomes and identifying new therapeutic targets.

SourceUniversity of Pittsburgh Schools of the Health Sciences·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJul 7, 2009

New mediator of smoking recruits

Researchers found high osteopontin levels in patients with interstitial lung disease and healthy smokers, while healthy non-smokers produced no osteopontin. Osteopontin expression could be stimulated by nicotine treatment, leading to immune cell recruitment and symptoms similar to smoking-related lung diseases.

SourceAmerican Journal of Pathology·JournalAmerican Journal Of Pathology·DateApr 24, 2009

Private foster care program leads to better long-term health

A private foster care program has been shown to significantly improve long-term health outcomes for teenagers placed in the program compared to those in public programs. The study found lower rates of mental disorders, ulcers, and cardiometabolic problems, but more respiratory disorders.

SourceJAMA Network·JournalArchives of General Psychiatry·DateJun 2, 2008

Beyond the terminal: Palliative care

Palliative care is now considered an integral part of serious respiratory disorders treatment, with individualized and integrated care promoting patient-focused symptom management. The ATS clinical policy statement emphasizes comprehensive care, including professional competence development and education.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateApr 15, 2008

Great apes endangered by human viruses

A new study published in Current Biology confirms the disease threat facing great apes, finding evidence of virus transmission from humans to wild apes. The study also shows that research and tourism projects have suppressed poaching of chimpanzees, outweighing mortality caused by human disease introduction.

SourceMax-Planck-Gesellschaft·JournalCurrent Biology·DateJan 25, 2008

New reovirus isolated

A new reovirus has been isolated from bats and can cause a serious but non-fatal respiratory illness in humans. The virus, named Melaka, is closely related to two other bat-borne reoviruses and can be transmitted between people.

SourceCSIRO Australia·JournalProceedings of the National Academy of Sciences·DateJun 26, 2007

Extra-aggressive form of idiopathic pulmonary fibrosis identified

A subset of patients with idiopathic pulmonary fibrosis (IPF) has been found to have a short duration of symptoms before diagnosis and an accelerated clinical course to end-stage disease. This 'rapid progressor' group is characterized by distinct gene expression patterns, which may lead to the development of new therapeutic interventions.

SourcePLOS·JournalPLOS ONE·DateMay 29, 2007